MENU
APRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aprea Therapeutics (APRE) Earnings Date & Reports
Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers... Show more
A.I. Advisor
published Earnings
APRE is expected to report earnings to fall 25.00% to -6 cents per share on March 30
Q4'26
Est.
$-0.07
Q3'26
Missed
by $0.01
Q2'26
Beat
by $0.11
Q1'26
Missed
by $0.10
Q4'25
Missed
by $0.01
The last earnings report on November 04 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 40.48K shares outstanding, the current market capitalization sits at 6.52M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company
Industry Biotechnology
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 215 948-4119
Employees
8
Web
https://www.aprea.com